Aibotics Inc.

0.0030+0.00 (+0%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · AIBT · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
575.71K
P/E (TTM)
-
Basic EPS (TTM)
-0.10
Dividend Yield
0%

Recent Filings

About

Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida.

CEO
Mr. Benjamin Kaplan
IPO
3/31/2006
Sector
Healthcare
Industry
Biotechnology